Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New Zambon macrolide with prolonged therapeutic efficacy

March 1, 2000

Novel triazole antifungal agents reported in Chinese literature

Feb. 28, 2000

Zyvox to be reviewed by FDA committee in late March

Feb. 28, 2000

SciClone awarded grant to study novel immunomodulator in TB

Feb. 25, 2000

NIAID signs agreement with MVI/PATH for malaria vaccine research

Feb. 25, 2000

CAN-296 may inhibit fungal ATPase-mediated proton pumping

Feb. 24, 2000

Antifungal activity of brasilinolide B described by Japanese research team

Feb. 23, 2000

Antiparasitic artemisinin derivatives designed at Hong Kong university

Feb. 23, 2000

Reticulose cleared for clinical trials in Argentina

Feb. 23, 2000

SPA-S-843 superior to amphotericin B in several in vitro assays

Feb. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...